Impact of the COVID-19 pandemic on long-term trends in the prevalence of diabetic ketoacidosis at diagnosis of paediatric type 1 diabetes: an international multicentre study based on data from 13 national diabetes registries
- PMID: 36202118
- PMCID: PMC9597608
- DOI: 10.1016/S2213-8587(22)00246-7
Impact of the COVID-19 pandemic on long-term trends in the prevalence of diabetic ketoacidosis at diagnosis of paediatric type 1 diabetes: an international multicentre study based on data from 13 national diabetes registries
Abstract
Background: An increased prevalence of diabetic ketoacidosis at diagnosis of type 1 diabetes in children was observed in various diabetes centres worldwide during the COVID-19 pandemic. We aimed to evaluate trends in the prevalence of diabetic ketoacidosis at diagnosis of paediatric type 1 diabetes before and during the COVID-19 pandemic, and to identify potential predictors of changes in diabetic ketoacidosis prevalence during the pandemic.
Methods: For this international multicentre study, we used data from 13 national diabetes registries (Australia, Austria, Czechia, Denmark, Germany, Italy, Luxembourg, New Zealand, Norway, Slovenia, Sweden, USA [Colorado], and Wales). The study population comprised 104 290 children and adolescents aged 6 months to younger than 18 years, who were diagnosed with type 1 diabetes between Jan 1, 2006, and Dec 31, 2021. The observed diabetic ketoacidosis prevalence in 2020 and 2021 was compared to predictions based on trends over the pre-pandemic years 2006-19. Associations between changes in diabetic ketoacidosis prevalence and the severity of the COVID-19 pandemic and containment measures were examined with excess all-cause mortality in the whole population and the Stringency Index from the Oxford COVID-19 Government Response Tracker.
Findings: 87 228 children and adolescents were diagnosed with type 1 diabetes between 2006 and 2019, 8209 were diagnosed in 2020, and 8853 were diagnosed in 2021. From 2006 to 2019, diabetic ketoacidosis at diagnosis of type 1 diabetes was present in 23 775 (27·3%) of 87 228 individuals and the mean annual increase in the prevalence of diabetic ketoacidosis in the total cohort from 2006 to 2019 was 1·6% (95% CI 1·3 to 1·9). The adjusted observed prevalence of diabetic ketoacidosis at diagnosis of type 1 diabetes was 39·4% (95% CI 34·0 to 45·6) in 2020 and 38·9% (33·6 to 45·0) in 2021, significantly higher than the predicted prevalence of 32·5% (27·8 to 37·9) for 2020 and 33·0% (28·3 to 38·5) for 2021 (p<0·0001 for both years). The prevalence of diabetic ketoacidosis was associated with the pandemic containment measures, with an estimated risk ratio of 1·037 (95% CI 1·024 to 1·051; p<0·0001) per ten-unit increase in the Stringency Index for 2020 and 1·028 (1·009 to 1·047; p=0·0033) for 2021, but was not significantly associated with excess all-cause mortality.
Interpretation: During the COVID-19 pandemic, there was a marked exacerbation of the pre-existing increase in diabetic ketoacidosis prevalence at diagnosis of type 1 diabetes in children. This finding highlights the need for early and timely diagnosis of type 1 diabetes in children and adolescents.
Funding: German Federal Ministry for Education and Research, German Robert Koch Institute, German Diabetes Association, German Diabetes Foundation, Slovenian Research Agency, Welsh Government, Central Denmark Region, and Swedish Association of Local Authorities and Regions.
Copyright © 2022 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of interests We declare no competing interests.
Figures



Comment in
-
Rise in diabetic ketoacidosis during the COVID-19 pandemic: several questions remain.Lancet Diabetes Endocrinol. 2022 Nov;10(11):763-765. doi: 10.1016/S2213-8587(22)00272-8. Epub 2022 Oct 3. Lancet Diabetes Endocrinol. 2022. PMID: 36202117 Free PMC article. No abstract available.
Similar articles
-
Temporal trends in diabetic ketoacidosis at diagnosis of paediatric type 1 diabetes between 2006 and 2016: results from 13 countries in three continents.Diabetologia. 2020 Aug;63(8):1530-1541. doi: 10.1007/s00125-020-05152-1. Epub 2020 May 8. Diabetologia. 2020. PMID: 32382815 Free PMC article.
-
The Silent Epidemic of Diabetic Ketoacidosis at Diagnosis of Type 1 Diabetes in Children and Adolescents in Italy During the COVID-19 Pandemic in 2020.Front Endocrinol (Lausanne). 2022 Jun 17;13:878634. doi: 10.3389/fendo.2022.878634. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35784550 Free PMC article.
-
Higher rates of diabetic ketoacidosis and admission to the paediatric intensive care unit among newly diagnosed children with type 1 diabetes in Kuwait during the COVID-19 pandemic.Diabetes Metab Res Rev. 2022 Mar;38(3):e3506. doi: 10.1002/dmrr.3506. Epub 2021 Oct 25. Diabetes Metab Res Rev. 2022. PMID: 34679258 Free PMC article.
-
Incidence of diabetic ketoacidosis during COVID-19 pandemic: a meta-analysis of 124,597 children with diabetes.Pediatr Res. 2023 Apr;93(5):1149-1160. doi: 10.1038/s41390-022-02241-2. Epub 2022 Aug 11. Pediatr Res. 2023. PMID: 35953513 Free PMC article.
-
Incidence of Diabetic Ketoacidosis Among Pediatrics With Type 1 Diabetes Prior to and During COVID-19 Pandemic: A Meta-Analysis of Observational Studies.Front Endocrinol (Lausanne). 2022 Mar 9;13:856958. doi: 10.3389/fendo.2022.856958. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35355556 Free PMC article.
Cited by
-
Impact of the COVID-19 pandemic on the incidence and clinical outcomes of diabetic ketoacidosis among male and female children with type 1 diabetes: systematic review and meta-analysis.F1000Res. 2023 Aug 10;12:72. doi: 10.12688/f1000research.128687.2. eCollection 2023. F1000Res. 2023. PMID: 39262444 Free PMC article.
-
Autoantibody test for type 1 diabetes in children: are there reasons to implement a screening program in the general population? A statement endorsed by the Italian Society for Paediatric Endocrinology and Diabetes (SIEDP-ISPED) and the Italian Society of Paediatrics (SIP).Ital J Pediatr. 2023 Jul 19;49(1):87. doi: 10.1186/s13052-023-01438-3. Ital J Pediatr. 2023. PMID: 37468976 Free PMC article. Review.
-
Diabetes and natural and man-made disasters: prevention, preparation, response and recovery.Diabetologia. 2025 Apr 15. doi: 10.1007/s00125-025-06406-6. Online ahead of print. Diabetologia. 2025. PMID: 40234304 Review.
-
Pediatric Diabetes and Diabetic Ketoacidosis After COVID-19: Challenges Faced and Lessons Learnt.Pediatric Health Med Ther. 2023 Sep 4;14:281-288. doi: 10.2147/PHMT.S384104. eCollection 2023. Pediatric Health Med Ther. 2023. PMID: 37691882 Free PMC article. Review.
-
Change in the Frequency of Diabetic Ketoacidosis in Children with Newly Diagnosed Type 1 Diabetes in the Central Anatolia Region of Turkey over the Years Before and After the Coronavirus Disease 2019 Pandemic: A Single-Center Experience.Turk Arch Pediatr. 2024 Mar;59(2):163-169. doi: 10.5152/TurkArchPediatr.2024.23255. Turk Arch Pediatr. 2024. PMID: 38454225 Free PMC article.
References
-
- Wolfsdorf JI, Glaser N, Agus M, et al. ISPAD Clinical Practice Consensus Guidelines 2018: diabetic ketoacidosis and the hyperglycemic hyperosmolar state. Pediatr Diabetes. 2018;19(suppl 27):155–177. - PubMed
-
- White NH. Diabetic ketoacidosis in children. Endocrinol Metab Clin North Am. 2000;29:657–682. - PubMed
-
- Dhatariya KK, Glaser NS, Codner E, Umpierrez GE. Diabetic ketoacidosis. Nat Rev Dis Primers. 2020;6:40. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials